GoHealth Valuation
| GOCO Stock | USD 2.16 0.04 1.82% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. GoHealth retains a regular Real Value of $3.52 per share. The prevalent price of the firm is $2.16. Our model calculates the value of GoHealth from examining the firm fundamentals such as Operating Margin of (2.39) %, return on asset of -0.021, and Return On Equity of -1.71 as well as evaluating its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GoHealth's valuation include:
Price Book 0.5052 | Enterprise Value | Enterprise Value Ebitda 5.4562 | Price Sales 0.0856 | Forward PE 555.5556 |
Undervalued
Today
Please note that GoHealth's price fluctuation is very risky at this time. Calculation of the real value of GoHealth is based on 3 months time horizon. Increasing GoHealth's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GoHealth is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GoHealth Stock. However, GoHealth's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.16 | Real 3.52 | Target 7.7 | Hype 2.17 |
The intrinsic value of GoHealth's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GoHealth's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GoHealth helps investors to forecast how GoHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GoHealth more accurately as focusing exclusively on GoHealth's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GoHealth's intrinsic value based on its ongoing forecasts of GoHealth's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GoHealth's closest peers.
GoHealth Cash |
|
GoHealth Revenue by Product
GoHealth Total Value Analysis
GoHealth is currently forecasted to have valuation of 674.96 M with market capitalization of 63.17 M, debt of 527.97 M, and cash on hands of 215.4 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GoHealth fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
674.96 M | 63.17 M | 527.97 M | 215.4 M |
GoHealth Investor Information
About 15.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.51. Some equities with similar Price to Book (P/B) outperform the market in the long run. GoHealth recorded a loss per share of 16.66. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 18th of November 2022. GoHealth may be sliding down financialy. It has an above-average chance of going through some form of financial crunch next quarter.GoHealth Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. GoHealth has an asset utilization ratio of 53.67 percent. This suggests that the Company is making $0.54 for each dollar of assets. An increasing asset utilization means that GoHealth is more efficient with each dollar of assets it utilizes for everyday operations.GoHealth Profitability Analysis
Considering the key profitability indicators obtained from GoHealth's historical financial statements, GoHealth may not be well positioned to generate adequate gross income at the present time. It has a very high chance of underperforming in March. Profitability indicators assess GoHealth's ability to earn profits and add value for shareholders.Net Loss | First Reported 2019-03-31 | Previous Quarter -54.3 M | Current Value -165.8 M | Quarterly Volatility 46.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.75 |
|
|
For GoHealth profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GoHealth to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GoHealth utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GoHealth's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GoHealth over time as well as its relative position and ranking within its peers.
GoHealth Earnings per Share Projection vs Actual
The next projected EPS of GoHealth is estimated to be -5.02285 with future projections ranging from a low of -5.635 to a high of -4.4225. GoHealth's most recent 12-month trailing earnings per share (EPS TTM) is at -16.66. Please be aware that the consensus of earnings estimates for GoHealth is based on EPS before non-recurring items and includes expenses related to employee stock options.GoHealth Earnings Estimation Breakdown
The calculation of GoHealth's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of GoHealth is estimated to be -5.02285 with the future projection ranging from a low of -5.635 to a high of -4.4225. Please be aware that this consensus of annual earnings estimates for GoHealth is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-5.63 Lowest | Expected EPS | -4.42 Highest |
GoHealth Earnings Projection Consensus
Suppose the current estimates of GoHealth's value are higher than the current market price of the GoHealth stock. In this case, investors may conclude that GoHealth is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and GoHealth's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 5 | 20.0% | -11.8 | -5.02285 | -16.66 |
GoHealth Ownership Allocation
GoHealth has a total of 16.09 Million outstanding shares. Over half of GoHealth's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.GoHealth Profitability Analysis
The company reported the previous year's revenue of 798.89 M. Net Loss for the year was (7.32 M) with profit before overhead, payroll, taxes, and interest of 594.32 M.About GoHealth Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of GoHealth. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of GoHealth based exclusively on its fundamental and basic technical indicators. By analyzing GoHealth's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of GoHealth's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of GoHealth. We calculate exposure to GoHealth's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GoHealth's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 768.5 M | 582.3 M | |
| Pretax Profit Margin | (0.01) | (0.01) | |
| Operating Profit Margin | (0.01) | (0.01) | |
| Gross Profit Margin | 0.75 | 0.59 |
GoHealth Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 10 M | |
| Quarterly Earnings Growth Y O Y | 4.241 | |
| Forward Price Earnings | 555.5556 |
GoHealth Current Valuation Indicators
GoHealth's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final GoHealth's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GoHealth, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GoHealth's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GoHealth's worth.When determining whether GoHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GoHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Gohealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Gohealth Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Will Property & Casualty Insurance sector continue expanding? Could GoHealth diversify its offerings? Factors like these will boost the valuation of GoHealth. Market participants price GoHealth higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every GoHealth data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 4.241 | Earnings Share (16.66) | Revenue Per Share | Quarterly Revenue Growth (0.71) | Return On Assets |
Understanding GoHealth requires distinguishing between market price and book value, where the latter reflects GoHealth's accounting equity. The concept of intrinsic value—what GoHealth's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push GoHealth's price substantially above or below its fundamental value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, GoHealth's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.